: +1 (646) 661-6066-
$2,000 Read More Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Metastatic Hepatocellular Carcinoma (HCC), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the de... -
$2,000 Read More Burns – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Burns, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ... -
$2,000 Read More Cough – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Cough, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ... -
$2,000 Read More Scar – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Scar, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of t... -
$2,000 Read More Pruritus – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Pruritus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action ... -
$2,000 Read More Open-Angle Glaucoma – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Open-Angle Glaucoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacologi... -
$2,000 Read More Nasopharyngeal Cancer – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Nasopharyngeal Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacolo... -
$2,000 Read More Thalassemia – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Thalassemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological acti... -
$2,000 Read More Ocular Hypertension – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Ocular Hypertension, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacologi... -
$2,000 Read More Metastatic Adenocarcinoma of The Pancreas – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Metastatic Adenocarcinoma of The Pancreas, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the de...
Sorry, there is no ad related to this category!
-
$4,995 Read More Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 –...
Type 1 Diabetes Mellitus (T1DM) is a chronic, progressive and serious disease characterized by a […]
-
$2,000 Read More Non Alcoholic Fatty Liver Disease (NAFLD) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Non Alcoholic Fatty Liver Disease (NAFLD) – Pipeline Review, H1 2016’, provides […]
-
$2,500 Read More Gonorrhea Global Clinical Trials Review, H1, 2016
This report provides top line data relating to the clinical trials on Gonorrhea. Report includes […]
-
$2,000 Read More Birch Pollen Allergy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Birch Pollen Allergy – Pipeline Review, H1 2016’, provides an overview of […]
-
$2,000 Read More Dyslipidemia – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Dyslipidemia, complete with analysis […]
-
$1,500 Read More Ceronco Biosciences – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Ceronco Biosciences – Product Pipeline Review – 2015’, provides an overview of […]
-
$2,000 Read More Amyloidosis – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Amyloidosis – Pipeline Review, H1 2016’, provides an overview of the Amyloidosis […]
-
$2,500 Read More Impetigo Global Clinical Trials Review, H1, 2016
This report provides top line data relating to the clinical trials on Impetigo. Report includes […]
-
$2,000 Read More Ischemia Reperfusion Injury – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Ischemia Reperfusion Injury, complete […]
-
$4,995 Read More Systemic Psoriasis Therapeutics in Asia-Pacific Markets to 2021 – Advent o...
GBI Research, the leading business intelligence provider, has released its latest research, “Systemic Psoriasis Therapeutics […]
